| Malloree Benade, SLP | |
|
16120 Ne 8th St, Bellevue, WA 98008-3937 | |
| (425) 747-4004 | |
| (425) 747-1069 |
| Full Name | Malloree Benade |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 16120 Ne 8th St, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093222648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL60811845 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Malloree Benade, SLP 16120 Ne 8th St, Bellevue, WA 98008-3937 Ph: (425) 747-4004 | Malloree Benade, SLP 16120 Ne 8th St, Bellevue, WA 98008-3937 Ph: (425) 747-4004 |
News Archive
The risk of monoclonal gammopathy of undetermined significance is significantly higher in individuals exposed than those not exposed to Agent Orange, shows a study of US Air Force personnel.
FUJIFILM Holdings Corporation (President: Shigehiro Nakajima) and Cellular Dynamics International, Inc. (CEO: Robert J. Palay), a leading developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced that the two companies have entered into a definitive agreement whereby Fujifilm will acquire CDI via an all-cash tender offer to be followed by a second step merger.
U.S. not-for-profit hospitals and health care systems continue to focus more on managing and reallocating their investment portfolios in order to provide capital stability and growth as well as building cash reserves.
Following the results of a worldwide study, U.S. regulators have given approval for the use of the drug Femara for women with early breast cancer directly after they have had surgery.
AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border merger creates a new, genomics-driven pharmaceutical company with leading edge capabilities for drug discovery and development, as well as two drug candidates in Phase II human trials for cancer.
› Verified 3 days ago
Alexandra Marie Gomez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1417 116th Ave Ne, Suite 110, Bellevue, WA 98004 Phone: 425-688-5900 Fax: 425-688-5912 | |
Elise Morrison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 Fax: 425-502-8425 | |
Andrea Nicole Jamieson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Mrs. Katherine Jeanne Oberhofer, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1417 116th Ave Ne Ste 110, Bellevue, WA 98004 Phone: 425-688-5911 Fax: 425-688-5912 | |
Mrs. Lori Anne Price, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Lummi Key, Bellevue, WA 98006 Phone: 425-643-2919 Fax: 425-657-0691 | |
Mackenzie Bush, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13333 Ne Bel Red Rd Ste 100, Bellevue, WA 98005 Phone: 501-352-0101 | |
Genenvieve Decantis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 |